{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:17:09Z","timestamp":1791404229763,"version":"4.3.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Radiation-induced lung injury (RILI) is one of the most common and fatal complications of thoracic radiotherapy, whereas no effective interventions are available. Andrographolide, an active component extracted from\n                    <jats:italic>Andrographis paniculate<\/jats:italic>\n                    , is prescribed as a treatment for upper respiratory tract infection. Here we report the potential radioprotective effect and mechanism of Andrographolide on RILI. C57BL\/6 mice were exposed to 18\u2009Gy of whole thorax irradiation, followed by intraperitoneal injection of Andrographolide every other day for 4 weeks. Andrographolide significantly ameliorated radiation-induced lung tissue damage, inflammatory cell infiltration, and pro-inflammatory cytokine release in the early phase and progressive fibrosis in the late phase. Moreover, Andrographolide markedly hampered radiation-induced activation of the AIM2 inflammasome and pyroptosis in vivo. Furthermore, bone marrow-derived macrophages (BMDMs) were exposed to 8\u2009Gy of X-ray radiation in vitro and Andrographolide significantly inhibited AIM2 inflammasome mediated-pyroptosis in BMDMs. Mechanistically, Andrographolide effectively prevented AIM2 from translocating into the nucleus to sense DNA damage induced by radiation or chemotherapeutic agents in BMDMs. Taken together, Andrographolide ameliorates RILI by suppressing AIM2 inflammasome mediated-pyroptosis in macrophage, identifying Andrographolide as a novel potential protective agent for RILI.\n                  <\/jats:p>","DOI":"10.1038\/s41419-019-2195-8","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T03:03:52Z","timestamp":1576811032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced lung inflammation and fibrosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Jian","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinni","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-3905","authenticated-orcid":false,"given":"Wenjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-0089","authenticated-orcid":false,"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"2195_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley, J. D. et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 16, 187\u2013199 (2015).","journal-title":"Lancet Oncol."},{"key":"2195_CR2","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1200\/JCO.2014.55.1184","volume":"32","author":"CM Fisher","year":"2014","unstructured":"Fisher, C. M. & Rabinovitch, R. Frontiers in radiotherapy for early-stage invasive breast cancer. J. Clin. Oncol. 32, 2894\u20132901 (2014).","journal-title":"J. Clin. Oncol."},{"key":"2195_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1470-2045(14)70482-6","volume":"16","author":"S Aluwini","year":"2015","unstructured":"Aluwini, S. et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial. Lancet Oncol. 16, 274\u2013283 (2015).","journal-title":"Lancet Oncol."},{"key":"2195_CR4","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1016\/S1470-2045(13)70569-2","volume":"15","author":"G De Meerleer","year":"2014","unstructured":"De Meerleer, G. et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol. 15, e170\u2013e177 (2014).","journal-title":"Lancet Oncol."},{"key":"2195_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3389\/fimmu.2017.00506","volume":"8","author":"A Kainthola","year":"2017","unstructured":"Kainthola, A. et al. Immunological aspect of radiation-induced pneumonitis, current treatment strategies, and future prospects. Front. Immunol. 8, 506 (2017).","journal-title":"Front. Immunol."},{"key":"2195_CR6","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1200\/JCO.2007.10.9777","volume":"25","author":"JR Carver","year":"2007","unstructured":"Carver, J. R. et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J. Clin. Oncol. 25, 3991\u20134008 (2007).","journal-title":"J. Clin. Oncol."},{"key":"2195_CR7","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00432-012-1284-1","volume":"138","author":"XJ Zhang","year":"2012","unstructured":"Zhang, X. J. et al. Prediction of radiation pneumonitis in lung cancer patients: a systematic review. J. Cancer Res. Clin. Oncol. 138, 2103\u20132116 (2012).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"2195_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0652-4","volume":"9","author":"J Im","year":"2018","unstructured":"Im, J., Lawrence, J., Seelig, D. & Nho, R. S. FoxM1-dependent RAD51 and BRCA2 signaling protects idiopathic pulmonary fibrosis fibroblasts from radiation-induced cell death. Cell Death Dis. 9, 584 (2018).","journal-title":"Cell Death Dis."},{"key":"2195_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.460","volume":"8","author":"YG Liu","year":"2017","unstructured":"Liu, Y. G. et al. NLRP3 inflammasome activation mediates radiation-induced pyroptosis in bone marrow-derived macrophages. Cell Death Dis. 8, e2579 (2017).","journal-title":"Cell Death Dis."},{"key":"2195_CR10","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1126\/science.aaf7532","volume":"354","author":"B Hu","year":"2016","unstructured":"Hu, B. et al. The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science 354, 765\u2013768 (2016).","journal-title":"Science"},{"key":"2195_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi, J., Gao, W. & Shao, F. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem. Sci. 42, 245\u2013254 (2017).","journal-title":"Trends Biochem. Sci."},{"key":"2195_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature07710","volume":"458","author":"T Fernandes-Alnemri","year":"2009","unstructured":"Fernandes-Alnemri, T., Yu, J. W., Datta, P., Wu, J. & Alnemri, E. S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509\u2013513 (2009).","journal-title":"Nature"},{"key":"2195_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung, V. et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514\u2013518 (2009).","journal-title":"Nature"},{"key":"2195_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"2195_CR15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12296","volume":"265","author":"SM Man","year":"2015","unstructured":"Man, S. M. & Kanneganti, T. D. Regulation of inflammasome activation. Immunol. Rev. 265, 6\u201321 (2015).","journal-title":"Immunol. Rev."},{"key":"2195_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","volume":"25","author":"SK Vanaja","year":"2015","unstructured":"Vanaja, S. K., Rathinam, V. A. & Fitzgerald, K. A. Mechanisms of inflammasome activation: recent advances and novel insights. Trends Cell Biol. 25, 308\u2013315 (2015).","journal-title":"Trends Cell Biol."},{"key":"2195_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ni.2237","volume":"13","author":"VA Rathinam","year":"2012","unstructured":"Rathinam, V. A., Vanaja, S. K. & Fitzgerald, K. A. Regulation of inflammasome signaling. Nat. Immunol. 13, 333\u2013342 (2012).","journal-title":"Nat. Immunol."},{"key":"2195_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature10759","volume":"481","author":"T Strowig","year":"2012","unstructured":"Strowig, T., Henao-Mejia, J., Elinav, E. & Flavell, R. Inflammasomes in health and disease. Nature 481, 278\u2013286 (2012).","journal-title":"Nature"},{"key":"2195_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bcp.2017.03.024","volume":"139","author":"WSD Tan","year":"2017","unstructured":"Tan, W. S. D., Liao, W., Zhou, S. & Wong, W. S. F. Is there a future for andrographolide to be an anti-inflammatory drug? Deciphering its major mechanisms of action. Biochem. Pharm. 139, 71\u201381 (2017).","journal-title":"Biochem. Pharm."},{"key":"2195_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.intimp.2014.03.015","volume":"20","author":"W Liu","year":"2014","unstructured":"Liu, W. et al. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1\/Th17 response. Int. Immunopharmacol. 20, 337\u2013345 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"2195_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.intimp.2012.09.002","volume":"14","author":"W Guo","year":"2012","unstructured":"Guo, W. et al. Water-soluble andrographolide sulfonate exerts anti-sepsis action in mice through down-regulating p38 MAPK, STAT3 and NF-kappaB pathways. Int. Immunopharmacol. 14, 613\u2013619 (2012).","journal-title":"Int. Immunopharmacol."},{"key":"2195_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.4161\/auto.28374","volume":"10","author":"W Guo","year":"2014","unstructured":"Guo, W. et al. Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer. Autophagy 10, 972\u2013985 (2014).","journal-title":"Autophagy"},{"key":"2195_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bcp.2016.09.024","volume":"121","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression. Biochem. Pharm. 121, 8\u201317 (2016).","journal-title":"Biochem. Pharm."},{"key":"2195_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.apsb.2016.02.002","volume":"6","author":"S Peng","year":"2016","unstructured":"Peng, S. et al. Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-kappaB pathways. Acta Pharm. Sin. B 6, 205\u2013211 (2016).","journal-title":"Acta Pharm. Sin. B"},{"key":"2195_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.intimp.2008.12.002","volume":"9","author":"AA Abu-Ghefreh","year":"2009","unstructured":"Abu-Ghefreh, A. A., Canatan, H. & Ezeamuzie, C. I. In vitro and in vivo anti-inflammatory effects of andrographolide. Int. Immunopharmacol. 9, 313\u2013318 (2009).","journal-title":"Int. Immunopharmacol."},{"key":"2195_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.200809-1516OC","volume":"179","author":"Z Bao","year":"2009","unstructured":"Bao, Z. et al. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am. J. Respir. Crit. Care Med. 179, 657\u2013665 (2009).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2195_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.taap.2018.10.005","volume":"360","author":"WSD Tan","year":"2018","unstructured":"Tan, W. S. D. et al. Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells. Toxicol. Appl. Pharm. 360, 120\u2013130 (2018).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2195_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.fertnstert.2013.04.028","volume":"100","author":"B Li","year":"2013","unstructured":"Li, B., Chen, M., Liu, X. & Guo, S. W. Constitutive and tumor necrosis factor-alpha-induced activation of nuclear factor-kappaB in adenomyosis and its inhibition by andrographolide. Fertil. Steril. 100, 568\u2013577 (2013).","journal-title":"Fertil. Steril."},{"key":"2195_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02351-0","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W. et al. Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nat. Commun. 8, 2168 (2017).","journal-title":"Nat. Commun."},{"key":"2195_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.159","volume":"8","author":"J Gao","year":"2017","unstructured":"Gao, J. et al. Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells. Cell Death Dis. 8, e2765 (2017).","journal-title":"Cell Death Dis."},{"key":"2195_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.stem.2008.03.009","volume":"2","author":"W Qiu","year":"2008","unstructured":"Qiu, W. et al. PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2, 576\u2013583 (2008).","journal-title":"Cell Stem Cell"},{"key":"2195_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1126\/science.1166202","volume":"327","author":"DG Kirsch","year":"2010","unstructured":"Kirsch, D. G. et al. p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 327, 593\u2013596 (2010).","journal-title":"Science"},{"key":"2195_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1126\/science.1060191","volume":"293","author":"F Paris","year":"2001","unstructured":"Paris, F. et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293\u2013297 (2001).","journal-title":"Science"},{"key":"2195_CR34","doi-asserted-by":"crossref","first-page":"80262","DOI":"10.18632\/oncotarget.12918","volume":"7","author":"S Peng","year":"2016","unstructured":"Peng, S. et al. Andrographolide ameliorates OVA-induced lung injury in mice by suppressing ROS-mediated NF-kappaB signaling and NLRP3 inflammasome activation. Oncotarget 7, 80262\u201380274 (2016).","journal-title":"Oncotarget"},{"key":"2195_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi, M. & Dixit, V. M. Mechanisms and functions of inflammasomes. Cell 157, 1013\u20131022 (2014).","journal-title":"Cell"},{"key":"2195_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2147\/OTT.S79433","volume":"8","author":"J Li","year":"2015","unstructured":"Li, J. et al. Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study. Onco Targets Ther. 8, 1129\u20131136 (2015).","journal-title":"Onco Targets Ther."},{"key":"2195_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10753-015-0234-x","volume":"39","author":"C Demirel","year":"2016","unstructured":"Demirel, C. et al. Inhibition of radiation-induced oxidative damage in the lung tissue: may acetylsalicylic acid have a positive role? Inflammation 39, 158\u2013165 (2016).","journal-title":"Inflammation"},{"key":"2195_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.radonc.2004.02.015","volume":"71","author":"G Rodrigues","year":"2004","unstructured":"Rodrigues, G., Lock, M., D'Souza, D., Yu, E. & Van Dyk, J. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer\u2013a systematic review. Radiother. Oncol. 71, 127\u2013138 (2004).","journal-title":"Radiother. Oncol."},{"key":"2195_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","volume":"10","author":"N Ueki","year":"2015","unstructured":"Ueki, N. et al. Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer. J. Thorac. Oncol. 10, 116\u2013125 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"2195_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2011.04.084","volume":"409","author":"L Gan","year":"2011","unstructured":"Gan, L. et al. Blockade of lysophosphatidic acid receptors LPAR1\/3 ameliorates lung fibrosis induced by irradiation. Biochem. Biophys. Res. Commun. 409, 7\u201313 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2195_CR41","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.2174\/13894501113149990198","volume":"14","author":"NH Ding","year":"2013","unstructured":"Ding, N. H., Li, J. J. & Sun, L. Q. Molecular mechanisms and treatment of radiation-induced lung fibrosis. Curr. Drug Targets 14, 1347\u20131356 (2013).","journal-title":"Curr. Drug Targets"},{"key":"2195_CR42","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ijrobp.2013.08.045","volume":"87","author":"DL Boothe","year":"2013","unstructured":"Boothe, D. L. et al. Transforming growth factor beta-1 (TGF-beta1) is a serum biomarker of radiation induced fibrosis in patients treated with intracavitary accelerated partial breast irradiation: preliminary results of a prospective study. Int. J. Radiat. Oncol. Biol. Phys. 87, 1030\u20131036 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"2195_CR43","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.ijrobp.2006.08.058","volume":"66","author":"PG Tsoutsou","year":"2006","unstructured":"Tsoutsou, P. G. & Koukourakis, M. I. Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int. J. Radiat. Oncol. Biol. Phys. 66, 1281\u20131293 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"2195_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/01902140490438915","volume":"30","author":"CJ Johnston","year":"2004","unstructured":"Johnston, C. J., Williams, J. P., Elder, A., Hernady, E. & Finkelstein, J. N. Inflammatory cell recruitment following thoracic irradiation. Exp. Lung Res. 30, 369\u2013382 (2004).","journal-title":"Exp. Lung Res."},{"key":"2195_CR45","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1073\/pnas.0911378107","volume":"107","author":"GO Ahn","year":"2010","unstructured":"Ahn, G. O. et al. Inhibition of Mac-1 (CD11b\/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc. Natl Acad. Sci. USA 107, 8363\u20138368 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2195_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1494488","volume":"7","author":"L Meziani","year":"2018","unstructured":"Meziani, L., Deutsch, E. & Mondini, M. Macrophages in radiation injury: a new therapeutic target. Oncoimmunology 7, e1494488 (2018).","journal-title":"Oncoimmunology"},{"key":"2195_CR47","first-page":"5685","volume":"8","author":"YL Chen","year":"2016","unstructured":"Chen, Y. L. et al. Inhibition of hepatic cells pyroptosis attenuates CLP-induced acute liver injury. Am. J. Transl. Res. 8, 5685\u20135695 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"2195_CR48","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1074\/jbc.M114.617886","volume":"290","author":"S Haldar","year":"2015","unstructured":"Haldar, S. et al. Inflammation and pyroptosis mediate muscle expansion in an interleukin-1beta (IL-1beta)-dependent manner. J. Biol. Chem. 290, 6574\u20136583 (2015).","journal-title":"J. Biol. Chem."},{"key":"2195_CR49","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.cub.2007.05.074","volume":"17","author":"L Feldmeyer","year":"2007","unstructured":"Feldmeyer, L. et al. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr. Biol. 17, 1140\u20131145 (2007).","journal-title":"Curr. Biol."},{"key":"2195_CR50","first-page":"123241","volume":"2013","author":"A Francois","year":"2013","unstructured":"Francois, A., Milliat, F., Guipaud, O. & Benderitter, M. Inflammation and immunity in radiation damage to the gut mucosa. Biomed. Res. Int. 2013, 123241 (2013).","journal-title":"Biomed. Res. Int."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2195-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2195-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T13:05:55Z","timestamp":1671195955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2195-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-2195-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"9 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"957"}}